Cargando…

Antiangiogenic Therapy with Human Apolipoprotein(a) Kringle V and Paclitaxel in a Human Ovarian Cancer Mouse Model()()

INTRODUCTION: The present study compared the effect of combination therapy using human apolipoprotein(a) kringle V (rhLK8) to conventional chemotherapy with paclitaxel for human ovarian carcinoma producing high or low levels of vascular endothelial growth factor (VEGF). MATERIALS AND METHODS: Human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Hyun-Kyung, Lee, Ho-Jeong, Yun, Seok-Joong, Lee, Sun-Joo, Langley, Robert R., Yoon, Yeup, Yi, Lee S.H., Bae, Duk-Soo, Kim, Jang-Seong, Kim, Sun Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145395/ https://www.ncbi.nlm.nih.gov/pubmed/25180060 http://dx.doi.org/10.1016/j.tranon.2014.04.005

Ejemplares similares

Human Apolipoprotein(a) Kringle V Inhibits Ischemia-Induced Retinal Neovascularization via Suppression of Fibronectin-Mediated Angiogenesis
por: Lim, Yangmi, et al.
Publicado: (2012)

Suppression of Colorectal Cancer Liver Metastasis by Apolipoprotein(a) Kringle V in a Nude Mouse Model through the Induction of Apoptosis in Tumor-Associated Endothelial Cells
por: Ahn, Jin-Hyung, et al.
Publicado: (2014)

Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism
por: Sticchi, Elena, et al.
Publicado: (2016)

The pharmacological bases of the antiangiogenic activity of paclitaxel
por: Bocci, Guido, et al.
Publicado: (2013)

Miguel Llinás and the Structure of the Kringle Fold
por: Patthy, Laszlo
Publicado: (2021)

Apolipoprotein(a) Inhibits In Vitro Tube Formation in Endothelial Cells: Identification of Roles for Kringle V and the Plasminogen Activation System
por: Liu, Lei, et al.
Publicado: (2013)

Prothrombin kringle-2, a mediator of microglial activation: new insight in Alzheimer’s disease pathogenesis
por: Lee, Jae Man, et al.
Publicado: (2022)

Antiangiogenic Activity of Acer tegmentosum Maxim Water Extract in Vitro and in Vivo
por: Kim, Eok-Cheon, et al.
Publicado: (2015)

Antitumour and antiangiogenic effects of IDN 5390, a novel C-seco taxane, in a paclitaxel-resistant human ovarian tumour xenograft
por: Petrangolini, G, et al.
Publicado: (2004)

Binding of the kringle‐2 domain of human plasminogen to streptococcal PAM‐type M‐protein causes dissociation of PAM dimers
por: Ayinuola, Olawole, et al.
Publicado: (2021)

Inhibition of Pathological Retinal Neovascularization by a Small Peptide Derived from Human Tissue-Type Plasminogen Kringle 2
por: Sun, Qian, et al.
Publicado: (2020)

Role of the kringle‐like domain in glycoprotein NMB for its tumorigenic potential
por: Xie, Rudy, et al.
Publicado: (2019)

Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer
por: Song, Taejong, et al.
Publicado: (2017)

Induction of microglial toll-like receptor 4 by prothrombin kringle-2: a potential pathogenic mechanism in Parkinson’s disease
por: Shin, Won-Ho, et al.
Publicado: (2015)

Antiangiogenic drugs in ovarian cancer
por: Kumaran, G C, et al.
Publicado: (2009)

Antiangiogenic therapies in ovarian cancer
por: Reinthaller, Alexander
Publicado: (2016)

Single-port access laparoscopic staging operation for a borderline ovarian tumor
por: Yoon, Aera, et al.
Publicado: (2011)

Prothrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic System
por: Leem, Eunju, et al.
Publicado: (2016)

Disruption of the kringle 1 domain of prothrombin leads to late onset mortality in zebrafish
por: Grzegorski, Steven J., et al.
Publicado: (2020)

NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells
por: Maehara, N, et al.
Publicado: (2001)

Control of hippocampal prothrombin kringle‐2 (pKr‐2) expression reduces neurotoxic symptoms in five familial Alzheimer's disease mice
por: Kim, Sehwan, et al.
Publicado: (2021)

Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer
por: Shin, Wonkyo, et al.
Publicado: (2018)

Nomogram to predict the number of oocytes retrieved in controlled ovarian stimulation
por: Moon, Kyoung Yong, et al.
Publicado: (2016)

Crystal structure of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (hROR1)
por: Guarino, Salvatore R., et al.
Publicado: (2022)

Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016)

Antiangiogenic Steroids in Human Cancer Therapy
por: Pietras, Richard J., et al.
Publicado: (2005)

Specific tail swelling pattern in hypo-osmotic solution as a predictor of DNA fragmentation status in human spermatozoa
por: Kim, Sung Woo, et al.
Publicado: (2019)

Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis
por: Paik, E Sun, et al.
Publicado: (2018)

Modification of Cyclic NGR Tumor Neovasculature-Homing Motif Sequence to Human Plasminogen Kringle 5 Improves Inhibition of Tumor Growth
por: Jiang, Weiwei, et al.
Publicado: (2012)

Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2018)

Perioperative administration of propranolol to women undergoing ovarian cancer surgery: A pilot study
por: Jang, Hye-In, et al.
Publicado: (2017)

Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2018)

Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016)

Tetranectin Binds to the Kringle 1-4 Form of Angiostatin and Modifies Its Functional Activity
por: Mogues, Tirsit, et al.
Publicado: (2004)

Potential Role of Kringle-Integrin Interaction in Plasmin and uPA Actions (A Hypothesis)
por: Takada, Yoshikazu
Publicado: (2012)

Voltage-Dependent Anion Channel-1, a Possible Ligand of Plasminogen Kringle 5
por: Liang, Yin-ku, et al.
Publicado: (2016)

Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?
por: García-Martínez, Elena, et al.
Publicado: (2020)

Inhibition of GP130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer
por: Park, Sun-Ae, et al.
Publicado: (2022)

Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification
por: Paik, E Sun, et al.
Publicado: (2015)

Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer
por: Zhang, Zheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_scfg78rmtje0o0uct3lh20bgi2